Softer demand, discontinuation of the low-margin nutrition trading business and the indirect effects of tariffs affected Innophos (IPHS) in Q3.
NEW YORK, Oct. 25, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Innophos Holdings, Inc. ("IPHS" or the "Company") (NASDAQ: IPHS) in connection with the proposed acquisition of the Company by an affiliate…
Weaker demand, discontinuation of low-margin nutrition trading business and effects of tariffs hurt Innophos' (IPHS) Q2 sales.
Innophos (IPHS) delivered earnings and revenue surprises of 22.86% and -7.99%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Innophos (IPHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IPHS earnings call for the period ending March 31, 2019.
Innophos (IPHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Innophos Holdings, Inc. (NASDAQ:IPHS) Q4 2018 Earnings Conference Call February 20, 2019 09:00 a.m. ET Company Representatives Kim Ann Mink - Chairman, Presiden